7570 MurD-like peptide ligases, peptide-binding domain
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Nucleosides, nucleotides, and analogues | 22 | 8.5 | 2.60× | q < 0.0001 | |
| Homogeneous metal compounds | 16 | 15.0 | 1.07× | q = 0.79 | |
| Homogeneous non-metal compounds | 6 | 6.6 | 0.91× | q = 1.00 | |
| Organic oxygen compounds | 0 | 6.1 | 0 | q = 5.0e-3 | |
| Organosulfur compounds | 1 | 0.6 | 1.59× | not tested | |
| Organic acids and derivatives | 7 | 4.7 | 1.48× | not tested | |
| Benzenoids | 2 | 2.2 | 0.90× | not tested | |
| Organoheterocyclic compounds | 2 | 4.7 | 0.42× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB16833 | ADP | Adenosine disphosphate | 21 |
| DB00171 | ATP | ATP | 11 |
| DB01673 | UMA | Uridine-5'-Diphosphate-N-Acetylmuramoyl-L-Alanine | 6 |
| DB02314 | UAG | Uridine-5'-Diphosphate-N-Acetylmuramoyl-L-Alanine-D-Glutamate | 6 |
| DB03909 | ACP | Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate | 5 |
| DB00130 | GLN | L-Glutamine | 4 |
| DB02930 | AGS | Adenosine 5'-[gamma-thio]triphosphate | 4 |
| DB03590 | API | 2,6-Diaminopimelic Acid | 3 |
| DB00131 | AMP | Adenosine phosphate | 2 |
| DB03345 | BME | Mercaptoethanol | 2 |
| DB00139 | SIN | Succinic acid | 1 |
| DB00142 | — | Glutamic acid | 1 |
| DB00293 | — | Raltitrexed | 1 |
| DB01762 | AAE | Acetoacetic acid | 1 |
| DB02301 | TMF | 5,10-Methylene-6-Hydrofolic Acid | 1 |
| DB03755 | ACQ | Adenosine-5'-[Beta, Gamma-Methylene]Tetraphosphate | 1 |
| DB03830 | PD8 | Phosphorylated Dihydropteroate | 1 |
| DB06813 | — | — | 1 |
| DB06970 | 2LG | 2-CHLORO-N-(3-CYANO-5,6-DIHYDRO-4H-CYCLOPENTA[B]THIOPHEN-2-YL)-5-DIETHYLSULFAMOYL-BENZAMIDE | 1 |
| DB08105 | LK1 | N-[(6-butoxynaphthalen-2-yl)sulfonyl]-L-glutamic acid | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| ADP | ADENOSINE-5'-DIPHOSPHATE | 22 |
| ATP | ADENOSINE-5'-TRIPHOSPHATE | 20 |
| MGmetal | MAGNESIUM ION | 11 |
| CL | CHLORIDE ION | 9 |
| ACP | PHOSPHOMETHYLPHOSPHONIC ACID ADENYLATE ESTER | 8 |
| ANP | PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER | 7 |
| UMA | URIDINE-5'-DIPHOSPHATE-N-ACETYLMURAMOYL-L-ALANINE | 7 |
| AGS | PHOSPHOTHIOPHOSPHORIC ACID-ADENYLATE ESTER | 4 |
| ZNmetal | ZINC ION | 4 |
| AMP | ADENOSINE MONOPHOSPHATE | 3 |
| API | 2,6-DIAMINOPIMELIC ACID | 3 |
| AZI | AZIDE ION | 3 |
| CAmetal | CALCIUM ION | 3 |
| A1J52 | (1~{R},2~{R})-1-[[4-[(5-~{tert}-butyl-1-methyl-pyrazol-3-yl)amino]-1~{H}-pyrazolo[3,4-d]pyrimidin-6-yl]amino]-2,3-dihydro-1~{H}-inden-2-ol | 2 |
| BME | BETA-MERCAPTOETHANOL | 2 |
| COmetal | COBALT (II) ION | 2 |
| UML | Uridine 5'Diphospho N-acetyl muramoyl-L-Alanyl-D-Glutamyl-L-Lysine | 2 |
| 051 | (1R,3R,4S)-4-[({6-[(4-CYANO-2-FLUOROBENZYL)OXY]NAPHTHALEN-2-YL}SULFONYL)AMINO]CYCLOHEXANE-1,3-DICARBOXYLIC ACID | 1 |
| 1LG | 2,4-DICHLORO-N-(3-CYANO-4,5,6,7-TETRAHYDRO-BENZOTHIOPHEN-2YL)-5-(MORPHOLINE-4-SULFONYL)-BENZAMIDE | 1 |
| 2GN | N-(6-(4-(2h-tetrazol-5-yl)benzyl)-3-cyano-4,5,6,7-tetrahydrothieno[2,3-c]pyridin-2-yl)-2,4-dichloro-5-(morpholinosulfonyl)benzamide | 1 |